• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情封锁对儿童代谢功能障碍相关脂肪性肝病与肾功能关系的影响

The Impact of COVID-19 Pandemic Lockdown on the Relationship between Pediatric MAFLD and Renal Function.

作者信息

Valentino Maria Sole, Marzuillo Pierluigi, Esposito Claudia, Bartiromo Mario, Nardolillo Michele, Villani Annalisa Valentina, Maresca Alessandro, Furcolo Giuseppe, Guarino Stefano, Miraglia Del Giudice Emanuele, Di Sessa Anna

机构信息

Department of Woman, Child, and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Unità Operativa Complessa di Pediatria e Pronto Soccorso Pediatrico, AORN Moscati, 83100 Avellino, Italy.

出版信息

J Clin Med. 2023 Mar 4;12(5):2037. doi: 10.3390/jcm12052037.

DOI:10.3390/jcm12052037
PMID:36902824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10003972/
Abstract

BACKGROUND

Both direct and indirect effects of COVID-19 have been found in all age groups. In particular, adult data demonstrated significant changes in patients with chronic and metabolic disease (e.g., obesity, diabetes, chronic kidney disease (CKD), and metabolic associated fatty liver dysfunction (MAFLD)), while similar pediatric evidence is still limited. We aimed at investigating the impact of the COVID-19 pandemic lockdown on the relationship between MAFLD and renal function in children with CKD due to congenital abnormalities of the kidney and urinary tract (CAKUT).

METHODS

A total of 21 children with CAKUT and CKD ≥ stage 1 underwent a comprehensive evaluation within 3 months before and 6 months after the first Italian lockdown.

RESULTS

At follow-up, CKD patients with MAFLD presented higher BMI-SDS, serum uric acid, triglycerides, and microalbuminuria levels and lower eGFR levels than those without MAFLD (all < 0.05). Higher ferritin and white blood cell concentrations were also found in patients with CKD diagnosed with MAFLD than peers without MAFLD (both = 0.01). Compared to children without MAFLD, a higher delta of BMI-SDS, eGFR levels, and microalbuminuria levels was found in patients with MAFLD.

CONCLUSIONS

Due to the negative influence of the COVID-19 lockdown on cardiometabolic health in childhood, a careful management of children with CKD is warranted.

摘要

背景

在所有年龄组中均发现了新冠病毒病(COVID-19)的直接和间接影响。特别是,成人数据显示,慢性和代谢性疾病(如肥胖、糖尿病、慢性肾脏病(CKD)和代谢相关脂肪性肝病(MAFLD))患者有显著变化,而类似的儿科证据仍然有限。我们旨在研究COVID-19大流行封锁对因先天性肾脏和尿路异常(CAKUT)导致CKD的儿童中MAFLD与肾功能之间关系的影响。

方法

共有21例CAKUT且CKD≥1期的儿童在意大利首次封锁前3个月和封锁后6个月内接受了全面评估。

结果

随访时,患有MAFLD的CKD患者比未患MAFLD的患者表现出更高的BMI-SDS、血清尿酸、甘油三酯和微量白蛋白尿水平,以及更低的估算肾小球滤过率(eGFR)水平(均P<0.05)。与未患MAFLD的同龄人相比,诊断为MAFLD的CKD患者还发现铁蛋白和白细胞浓度更高(均P = 0.01)。与未患MAFLD的儿童相比,患有MAFLD的患者BMI-SDS、eGFR水平和微量白蛋白尿水平的变化更大。

结论

由于COVID-19封锁对儿童心脏代谢健康有负面影响,因此有必要对CKD儿童进行仔细管理。

相似文献

1
The Impact of COVID-19 Pandemic Lockdown on the Relationship between Pediatric MAFLD and Renal Function.新冠疫情封锁对儿童代谢功能障碍相关脂肪性肝病与肾功能关系的影响
J Clin Med. 2023 Mar 4;12(5):2037. doi: 10.3390/jcm12052037.
2
Effects of Lockdown for COVID-19 Pandemic on Chronic Kidney Disease Progression in Children with Congenital Anomalies of the Kidney and Urinary Tract: A Retrospective Pilot Study.2019年冠状病毒病大流行期间封锁措施对先天性肾脏和尿路异常儿童慢性肾脏病进展的影响:一项回顾性试点研究
Children (Basel). 2023 Jan 6;10(1):123. doi: 10.3390/children10010123.
3
Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.代谢相关脂肪性肝病比单纯性脂肪肝或非酒精性脂肪性肝病更能预测慢性肾脏病的发生。
Nephrol Dial Transplant. 2023 Feb 28;38(3):700-711. doi: 10.1093/ndt/gfac188.
4
Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.代谢相关脂肪性肝病与慢性肾脏病的相关性:一项基于中国人群的研究。
Ren Fail. 2022 Dec;44(1):1996-2005. doi: 10.1080/0886022X.2022.2144373.
5
Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.代谢相关脂肪性肝病、2 型糖尿病及其代谢目标达标与慢性肾脏病风险的相关性。
Front Public Health. 2022 Nov 7;10:1047794. doi: 10.3389/fpubh.2022.1047794. eCollection 2022.
6
MAFLD and risk of CKD.MAFLD 和慢性肾脏病风险。
Metabolism. 2021 Feb;115:154433. doi: 10.1016/j.metabol.2020.154433. Epub 2020 Nov 16.
7
MAFLD and CKD: An Updated Narrative Review.MAFLD 和 CKD:更新的叙述性综述。
Int J Mol Sci. 2022 Jun 23;23(13):7007. doi: 10.3390/ijms23137007.
8
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.代谢相关脂肪性肝病与慢性肾脏病发病风险的关系:一项全国性队列研究。
Diabetes Metab. 2022 Jul;48(4):101344. doi: 10.1016/j.diabet.2022.101344. Epub 2022 Mar 25.
9
Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017-2018.代谢相关脂肪性肝病与慢性肾脏病之间的关联:一项基于2017 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究
Diabetes Metab Syndr Obes. 2021 Apr 22;14:1751-1761. doi: 10.2147/DMSO.S292926. eCollection 2021.
10
Metabolic Dysfunction-Associated Fatty Liver Disease in Newly Diagnosed, Treatment-Naive Hypertensive Patients and Its Association with Cardiorenal Risk Markers.代谢功能障碍相关脂肪性肝病在初诊、未经治疗的高血压患者中的表现及其与心肾风险标志物的关系。
High Blood Press Cardiovasc Prev. 2023 Jan;30(1):63-72. doi: 10.1007/s40292-023-00558-5. Epub 2023 Jan 10.

引用本文的文献

1
Web of Science-Based Visualization of Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric and Adolescent Populations: A Bibliometric Study.基于科学网的儿童和青少年人群中代谢功能障碍相关脂肪性肝病的可视化分析:一项文献计量学研究
Health Sci Rep. 2025 Jan 29;8(2):e70409. doi: 10.1002/hsr2.70409. eCollection 2025 Feb.
2
Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study.非酒精性脂肪性肝病患者新冠病毒疾病严重程度的基因组学洞察:一项单中心前瞻性队列研究
Front Genet. 2024 Sep 4;15:1460318. doi: 10.3389/fgene.2024.1460318. eCollection 2024.
3
Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective.代谢功能障碍相关脂肪性肝病与肾功能之间的相互作用:一个有趣的儿科视角。
World J Gastroenterol. 2024 Apr 21;30(15):2081-2086. doi: 10.3748/wjg.v30.i15.2081.
4
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis.遗传因素预测 COVID-19 和 MAFLD 共病病程:综合分析。
Viruses. 2023 Aug 12;15(8):1724. doi: 10.3390/v15081724.
5
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.新型冠状病毒肺炎与代谢相关脂肪性肝病的关系:当前证据概述。
Viruses. 2023 Apr 27;15(5):1072. doi: 10.3390/v15051072.

本文引用的文献

1
Effects of Lockdown for COVID-19 Pandemic on Chronic Kidney Disease Progression in Children with Congenital Anomalies of the Kidney and Urinary Tract: A Retrospective Pilot Study.2019年冠状病毒病大流行期间封锁措施对先天性肾脏和尿路异常儿童慢性肾脏病进展的影响:一项回顾性试点研究
Children (Basel). 2023 Jan 6;10(1):123. doi: 10.3390/children10010123.
2
The Effects of COVID-19 Pandemic and Lockdown on Pediatric Nutritional and Metabolic Diseases: A Narrative Review.新冠疫情和封控对儿科营养和代谢性疾病的影响:一项叙述性综述。
Nutrients. 2022 Dec 24;15(1):88. doi: 10.3390/nu15010088.
3
Tangled relationship between insulin resistance and microalbuminuria in children with obesity.肥胖儿童胰岛素抵抗与微量白蛋白尿之间的复杂关系。
World J Clin Pediatr. 2022 Nov 9;11(6):455-462. doi: 10.5409/wjcp.v11.i6.455.
4
Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.代谢相关脂肪性肝病、2 型糖尿病及其代谢目标达标与慢性肾脏病风险的相关性。
Front Public Health. 2022 Nov 7;10:1047794. doi: 10.3389/fpubh.2022.1047794. eCollection 2022.
5
Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study.代谢相关脂肪性肝病与慢性肾脏病的相关性:一项基于中国人群的研究。
Ren Fail. 2022 Dec;44(1):1996-2005. doi: 10.1080/0886022X.2022.2144373.
6
Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations.代谢相关脂肪性肝病与慢性肾脏病的相互作用:流行病学、病理生理机制与治疗策略。
World J Gastroenterol. 2022 Oct 21;28(39):5691-5706. doi: 10.3748/wjg.v28.i39.5691.
7
COVID-19 mortality and deprivation: pandemic, syndemic, and endemic health inequalities.新冠死亡率与贫困:大流行、综合征和固有健康不平等。
Lancet Public Health. 2022 Nov;7(11):e966-e975. doi: 10.1016/S2468-2667(22)00223-7.
8
Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study.新冠疫情封锁对成年人非酒精性脂肪肝和胰岛素抵抗的影响:一项疫情封锁前后的纵向研究。
Nutrients. 2022 Jul 7;14(14):2795. doi: 10.3390/nu14142795.
9
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD.COVID-19 大流行:对 SARS-CoV-2 感染与 MAFLD 之间相互作用的深入了解。
Int J Biol Sci. 2022 Jul 11;18(12):4756-4767. doi: 10.7150/ijbs.72461. eCollection 2022.
10
SARS-CoV-2 infection and liver involvement.严重急性呼吸综合征冠状病毒 2 感染与肝脏受累。
Hepatol Int. 2022 Aug;16(4):755-774. doi: 10.1007/s12072-022-10364-1. Epub 2022 Jun 29.